CSP403 - Trial of varicella zoster vaccine for the prevention of herpes zoster and its complications.

Trial Profile

CSP403 - Trial of varicella zoster vaccine for the prevention of herpes zoster and its complications.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Herpes zoster; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Acronyms SPS
  • Most Recent Events

    • 12 Apr 2016 Results (post hoc pooled analysis of this and other study, n = 28785) assessing severe injection-site and systemic AEs presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases.
    • 25 Oct 2008 Results published as an abstract in the proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America.
    • 01 Mar 2008 Results reported in the Journal of Infectious Disease.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top